Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending November 5, 2021

Overall drug TRx +0.2% w/w

Vascepa
TRx 79,838; +2.9% (+2,223) w/w; -15.4% y/y
NRx 35,526; +2.0% (+686) w/w; -17.3% y/y
Ref 44,312; +3.6% (+1,537) w/w; -13.7% y/y

Lovaza (Generic & Brand)
TRx 62,581; +0.2% (+110) w/w; -1.9% y/y
NRx 30,555; +0.3% (+105) w/w; -7.9% y/y
Ref 32,026; +0.0% (+5) w/w; +4.5% y/y

Generic Vascepa
TRx 21,148; -0.0% (-1) w/w; As % of total V: 20.9%
NRx 12,021; -0.8% (-94) w/w; As % of total V: 25.3%
Ref 9,127; +1.0% (+93) w/w; As % of total V: 17.1%

Generic Vascepa by Manufacturer
Hikma - TRx 12,496 (-59); Generic share 59.1%; Total V share 12.4%
Reddy - TRx 8,652 (+58); Generic share 40.9%; Total V share 8.6%

TRx Vascepa + Generic Vascepa
TRx 100,886; +2.2% (+2,222)
NRx 47,548; +1.3% (+592)
Ref 53,439; +3.1% (+1,630)